ReviewFrontiers in psychiatry2021
Do Cannabis Users Reduce Their THC Dosages When Using More Potent Cannabis Products? A Review.
Review in Frontiers in psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.
- High-Potency Cannabis Use and Health: A Systematic Review of Observational and Experimental Studies.The American journal of psychiatry · 2025Pooled it
- Sex differences in acute cannabis effects revisited: Results from two randomized, controlled trials.Addiction biology · 2022Trial
- Preliminary validation of an experimental cannabis marketplace and its psychometric properties against an established measure of cannabis demand.Drug and alcohol dependence · 2026Article
- International Policy Approaches for Higher THC Cannabis Products: Are They Applicable to the Australian Medicinal Cannabis Framework?Drug and alcohol review · 2026Review
- Cannabis dispensary exposure and smoked, vaped and edible cannabis use among young adults: Comparison of web-scraped and government-maintained registries.Addiction (Abingdon, England) · 2026Article
- Higher THC Concentration Medicinal Cannabis Products Efficacy and Safety Considerations: A Rapid Review.Drug and alcohol review · 2026Review
- Effects of legal-market cannabis and alcohol on verbal learning and memory.Psychopharmacology · 2026Article
- Recent Advances in the Science of Cannabis-Impaired Driving.Current addiction reports · 2026Review
- High potency cannabis flower use is associated with heavier consumption and risk for cannabis use disorder among young adults in California, United States.Addiction (Abingdon, England) · 2025Article
- Self-titration of cannabis consumption: An epidemiological perspective.Journal of psychiatric research · 2025Article
- Cannabinoid profiling across toxicology samples in adolescents and young adults by route of administration and in relation to depression symptoms.Journal of analytical toxicology · 2025Article
- An analysis of the cultivation, consumption and composition of home-grown cannabis following decriminalisation in the Australian Capital Territory.Scientific reports · 2025Article
- Dose of Product or Product Concentration: A Comparison of Change in Heart Rate by THC Concentration for Participants Using Cannabis Daily and Occasionally.Cannabis and cannabinoid research · 2025Article
- Cannabis concentrate vaping chemistry.Frontiers in toxicology · 2025Review
- Changes in Cannabis Use From 2014 to 2019 Among Young Adults in Washington State.American journal of preventive medicine · 2024Article
- On offer to Ontario consumers three years after legalization: A profile of cannabis products, cannabinoid content, plant type, and prices.Frontiers in psychiatry · 2023Article
- Trends and Socio-Demographic Differences of Cannabis Vaping in the USA and Canada.International journal of environmental research and public health · 2022Article
- Association of Tetrahydrocannabinol Content and Price in Herbal Cannabis Products Offered by Dispensaries in California: A Purview of Consumers/Patients.Frontiers in public health · 2022Article
- Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates.The Lancet regional health. Europe · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.